Abstract | AIM: MATERIAL OF STUDY: Six patients, whom have been suffering unilateral facial palsy with an House-Brackmann score grade from III to VI, were included in this study for a residual facial asymmetry and contralateral hyperkinesis after previous facial reanimation. They were treated with 50 units of botulinum toxin type A injected in muscles of the unaffected side of face to improve muscular ability and facial symmetry. RESULTS: This study demonstrated reduction in contralateral hyperkinesis and facial asymmetry that lasted approximately 120 days. All patients reported satisfactory results with the treatment. COMMENTS: DISCUSSION AND COMMENTS:
Botulinum toxin type A injections may be an indispensable technique as a nonsurgical treatment or as a complementary measure in postsurgical treatments and should be certainly considered for temporary or permanent asymmetries in patients who suffer from facial palsy. CONCLUSIONS:
|
Authors | Davina Bartoli, Andrea Battisti, Andrea Cassoni, Valentina Terenzi, Marco Della Monaca, Mario Pagnoni, Valentino Valentini, Paolo Priore |
Journal | Annali italiani di chirurgia
(Ann Ital Chir)
2015 May-Jun
Vol. 86
Issue 3
Pg. 201-6
ISSN: 2239-253X [Electronic] Italy |
PMID | 26229045
(Publication Type: Journal Article)
|
Chemical References |
- Neuromuscular Agents
- Botulinum Toxins, Type A
|
Topics |
- Botulinum Toxins, Type A
(therapeutic use)
- Facial Asymmetry
(drug therapy)
- Facial Paralysis
(surgery)
- Humans
- Hyperkinesis
(drug therapy)
- Neuromuscular Agents
(therapeutic use)
|